Emerging biomarkers in urothelial carcinoma: Challenges and opportunities

Advanced urothelial carcinoma (UC) is a very important cause of cancer-related morbidity and mortality with, until recently, only a few available therapeutic options. The treatment landscape has dramatically changed in recent years with the introduction of immune checkpoint inhibitors and the develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreatos, Nikolaos, Iyer, Gopa, Grivas, Petros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387954/
https://www.ncbi.nlm.nih.gov/pubmed/32920502
http://dx.doi.org/10.1016/j.ctarc.2020.100179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387954/
https://www.ncbi.nlm.nih.gov/pubmed/32920502
http://dx.doi.org/10.1016/j.ctarc.2020.100179

Ejemplares similares